235 related articles for article (PubMed ID: 28361850)
21. Expressiveness of Bone Markers in Breast Cancer with Bone Metastases.
Zulauf N; Brüggmann D; Groneberg D; Oremek GM
Oncology; 2019; 97(4):236-244. PubMed ID: 31412345
[TBL] [Abstract][Full Text] [Related]
22. Negative effect of serotonin-norepinephrine reuptake inhibitor therapy on rat bone tissue after orchidectomy.
Fekete S; Simko J; Mzik M; Karesova I; Zivna H; Zivny P; Pavliková L; Palicka V
Eur J Pharmacol; 2015 Aug; 761():65-9. PubMed ID: 25934570
[TBL] [Abstract][Full Text] [Related]
23. Biochemical markers of bone turnover in diagnosis of myeloma bone disease.
Dizdar O; Barista I; Kalyoncu U; Karadag O; Hascelik G; Cila A; Pinar A; Celik I; Kars A; Tekuzman G
Am J Hematol; 2007 Mar; 82(3):185-91. PubMed ID: 17022050
[TBL] [Abstract][Full Text] [Related]
24. Urinary alpha and beta C-telopeptides of collagen I: clinical implications in bone remodeling in patients with anorexia nervosa.
de la Piedra C; Calero JA; Traba ML; Asensio MD; Argente J; Muñoz MT
Osteoporos Int; 1999; 10(6):480-6. PubMed ID: 10663349
[TBL] [Abstract][Full Text] [Related]
25. Clinical utility of C-terminal telopeptide of type 1 collagen in multiple myeloma.
Ting KR; Brady JJ; Hameed A; Le G; Meiller J; Verburgh E; Bayers C; Benjamin D; Anderson KC; Richardson PG; Dowling P; Clynes M; Fitzgibbon MC; O'Gorman P
Br J Haematol; 2016 Apr; 173(1):82-8. PubMed ID: 26787413
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis.
Sprague SM; Bellorin-Font E; Jorgetti V; Carvalho AB; Malluche HH; Ferreira A; D'Haese PC; Drüeke TB; Du H; Manley T; Rojas E; Moe SM
Am J Kidney Dis; 2016 Apr; 67(4):559-66. PubMed ID: 26321176
[TBL] [Abstract][Full Text] [Related]
27. The direct effect of specific training and walking on bone metabolic markers in young adults with peak bone mass.
Gombos Császár G; Bajsz V; Sió E; Steinhausz Tóth V; Schmidt B; Szekeres L; Kránicz J
Acta Physiol Hung; 2014 Jun; 101(2):205-15. PubMed ID: 24603147
[TBL] [Abstract][Full Text] [Related]
28. Serum markers of bone turnover in children and adolescents with classic galactosemia.
Gajewska J; Ambroszkiewicz J; Radomyska B; Chełchowska M; Ołtarzewski M; Laskowska-Klita T; Milanowski A
Adv Med Sci; 2008; 53(2):214-20. PubMed ID: 18650146
[TBL] [Abstract][Full Text] [Related]
29. Role of type I collagen C telopeptide, bone-specific alkaline phosphatase and osteocalcin in the assessment of bone status in postmenopausal women.
Trento LK; Pietropolli A; Ticconi C; Gravotta E; De Martino MU; Fabbri A; Piccione E
J Obstet Gynaecol Res; 2009 Feb; 35(1):152-9. PubMed ID: 19215563
[TBL] [Abstract][Full Text] [Related]
30. Decreased beta-isomerization of the C-terminal telopeptide of type I collagen alpha 1 chain in Paget's disease of bone.
Garnero P; Fledelius C; Gineyts E; Serre CM; Vignot E; Delmas PD
J Bone Miner Res; 1997 Sep; 12(9):1407-15. PubMed ID: 9286756
[TBL] [Abstract][Full Text] [Related]
31. Direct effects of physical training on markers of bone metabolism and serum sclerostin concentrations in older adults with low bone mass.
Gombos GC; Bajsz V; Pék E; Schmidt B; Sió E; Molics B; Betlehem J
BMC Musculoskelet Disord; 2016 Jun; 17():254. PubMed ID: 27278385
[TBL] [Abstract][Full Text] [Related]
32. [Correlation of the levels of the bone turnover markers BAP and β-CTX with bone metastasis progress in lung cancer patients].
Tang Q; Zhao H; Jia R; Liu L
Zhongguo Fei Ai Za Zhi; 2013 Mar; 16(3):144-7. PubMed ID: 23514943
[TBL] [Abstract][Full Text] [Related]
33. Effect of surgical menopause and Paget's disease of bone on the isomerization of type I collagen carboxyterminal telopeptide: evolution after antiresorptive therapy.
Peris P; Alvarez L; Monegal A; Guañabens N; Durán M; Echevarría M; Ros I; Ballesta AM; Muñoz-Gómez J
J Bone Miner Metab; 2002; 20(2):116-20. PubMed ID: 11862534
[TBL] [Abstract][Full Text] [Related]
34. The use of biochemical markers of bone remodeling in multiple myeloma: a report of the International Myeloma Working Group.
Terpos E; Dimopoulos MA; Sezer O; Roodman D; Abildgaard N; Vescio R; Tosi P; Garcia-Sanz R; Davies F; Chanan-Khan A; Palumbo A; Sonneveld P; Drake MT; Harousseau JL; Anderson KC; Durie BG;
Leukemia; 2010 Oct; 24(10):1700-12. PubMed ID: 20811404
[TBL] [Abstract][Full Text] [Related]
35. Bone alkaline phosphatase isoforms in hemodialysis patients with low versus non-low bone turnover: a diagnostic test study.
Haarhaus M; Monier-Faugere MC; Magnusson P; Malluche HH
Am J Kidney Dis; 2015 Jul; 66(1):99-105. PubMed ID: 25843703
[TBL] [Abstract][Full Text] [Related]
36. Clinical utility of biochemical bone turnover markers in children and adolescents with osteosarcoma.
Ambroszkiewicz J; Gajewska J; Klepacka T; Chełchowska M; Laskowska-Klita T; Woźniak W
Adv Med Sci; 2010; 55(2):266-72. PubMed ID: 21084254
[TBL] [Abstract][Full Text] [Related]
37. [Biochemical markers of bone formation activity in children with neoplasms].
Muszyńska-Rosłan K; Krawczuk-Rybak M; Protas P; Siedlecka E; Wiśniewska M; Wołczyński S
Wiad Lek; 2005; 58(1-2):29-35. PubMed ID: 15991550
[TBL] [Abstract][Full Text] [Related]
38. Clinical significance of bone alkaline phosphatase isoforms, including the novel B1x isoform, in mild to moderate chronic kidney disease.
Haarhaus M; Fernström A; Magnusson M; Magnusson P
Nephrol Dial Transplant; 2009 Nov; 24(11):3382-9. PubMed ID: 19542194
[TBL] [Abstract][Full Text] [Related]
39. Serum TRACP 5b is a useful marker for monitoring alendronate treatment: comparison with other markers of bone turnover.
Nenonen A; Cheng S; Ivaska KK; Alatalo SL; Lehtimäki T; Schmidt-Gayk H; Uusi-Rasi K; Heinonen A; Kannus P; Sievänen H; Vuori I; Väänänen HK; Halleen JM
J Bone Miner Res; 2005 Oct; 20(10):1804-12. PubMed ID: 16355501
[TBL] [Abstract][Full Text] [Related]
40. Serum levels of carboxy-terminal telopeptide of type-I collagen are elevated in patients with multiple myeloma showing skeletal manifestations in magnetic resonance imaging but lacking lytic bone lesions in conventional radiography.
Jakob C; Zavrski I; Heider U; Bollow M; Schulz CO; Fleissner C; Eucker J; Michael R; Hamm B; Possinger K; Sezer O
Clin Cancer Res; 2003 Aug; 9(8):3047-51. PubMed ID: 12912955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]